HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Encopresis

Incontinence of feces not due to organic defect or illness.
Networked: 143 relevant articles (18 outcomes, 15 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Constipation
2. Fecal Incontinence
3. Anorectal Malformations
4. Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
5. Enuresis

Experts

1. Loening-Baucke, Vera: 5 articles (03/2004 - 04/2002)
2. Horn, Debra: 3 articles (12/2015 - 01/2005)
3. Bilgiç, Ayhan: 3 articles (10/2015 - 03/2011)
4. Cox, Daniel J: 3 articles (06/2008 - 04/2002)
5. Pashankar, Dinesh S: 3 articles (05/2005 - 07/2003)
6. Nurko, Samuel: 2 articles (12/2017 - 04/2002)
7. Croffie, Joseph: 2 articles (12/2015 - 04/2010)
8. Yılmaz, Savaş: 2 articles (01/2015 - 04/2014)
9. Hergüner, Sabri: 2 articles (04/2014 - 04/2012)
10. Combs, Andrew J: 2 articles (09/2013 - 07/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Encopresis:
1. LaxativesIBA
2. Mineral Oil (Liquid Paraffin)FDA LinkGeneric
3. Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
4. polyethylene glycol 3350 (miralax)FDA LinkGeneric
5. Cisapride (Propulsid)FDA Link
6. Norepinephrine (Noradrenaline)FDA LinkGeneric
7. (1-6)-alpha-glucomannan (glucomannan)IBA
8. Cholinergic Antagonists (Anticholinergics)IBA
09/01/2013 - "Anticholinergics, despite their constipating effect, given for treatment of detrusor overactivity resolved encopresis in most children with this bowel dysfunction."
09/01/2013 - "All but 1 patient with encopresis had associated urgency and detrusor overactivity, and the encopresis resolved in 75% of patients after initiation of anticholinergic therapy. "
07/01/2009 - "The major themes covered this year included diagnosis of NNVD by symptomatology and relationship to subsequent urodynamic findings and treatment outcomes; effect of bladder volumes and overdistention, test position, catheter size, catheter in or out during voiding and sex on flow rate, flow pattern, voiding pressures, presence of overactivity and interpretation of findings on both urodynamic studies and uroflow testing; associations between bowel disorders (constipation and encopresis) and NNVD, associations between behavioral disorders and bowel disorders as reflected by treatment response and effect on behavior; efficacy studies on symptom-directed therapies in NNVD, comparison of different biofeedback programs for treating dysfunctional voiding, Botox injections for overactive bladder and an adult anticholinergic for overactive bladder that underwent testing in children; enuresis topics included anticholinergics for treating monosyptomatic enuresis refractory to desmopressin, prevalence of enuresis when screening large numbers of healthy school-age children and its association with certain family characteristics and other bowel and bladder complaints and an update on the association of fluctuation of vasopressin and nightly urine output and its role in patient selection for desmopressin therapy. "
9. Type A Botulinum Toxins (Botox)FDA Link
10. Octreotide (Sandostatin)FDA LinkGeneric

Therapies and Procedures

1. Psychology Biofeedback (Biofeedback)
2. Therapeutics
3. Musculoskeletal Manipulations (Manipulative Therapy)
4. Aftercare (After-Treatment)
5. Enema (Enemas)